The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

Clifford Lane, a 45-year veteran of the NIH and close confidant of Fauci as NIAID deputy director for clinical research, and ...

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

The U.S. Food and Drug Administration has missed the deadline for making a decision on Novavax's COVID-19 vaccine, a source ...

The move comes amid HHS Secretary Robert F. Kennedy Jr.’s decision to force out the top official responsible for reviewing ...

RNA vaccines, like COVID-19 vaccines, work better if patients are in a good mood, finds new research by Cardiff University.

Public Health Scotland (PHS) is urging eligible individuals to get the spring COVID-19 vaccine before the programme ends on ...

The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...

Although the bivalent COVID-19 vaccine conferred moderate protection against symptomatic disease, hybrid immunity provided the strongest protection.

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.

Northern Ireland's Chief Medical Officer Professor Sir Michael McBride said: “It is important we remember Covid-19 is just ...